Biomarker may predict immunotherapy response in liver cancer

A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.

How to get Democrats, Republicans to strengthen democracy

A “megastudy” that surveyed more than 32,000 Democrats and Republicans identified effective strategies for reducing political polarization in the U.S.

How zoning can reshape communities – this time for better

In a new book, “Key to the City: How Zoning Shapes Our World,” Sara Bronin reveals zoning’s impact and how it can be harnessed for good.

Unique immune response in lupus paves the way for new treatments

The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.

Climate change brings challenges, and opportunities, to Finger Lakes wineries

In a wetter, hotter, more turbulent weather world, New York state wineries will endure new hardship, but they may be better off than most. 

Astronomy professor Anna Ho named Packard Fellow

Anna Ho, assistant professor of astronomy in the College of Arts and Sciences, has been named a Packard Fellow for Science and Engineering. The fellowship includes $875,000 in unrestricted funds to be used for research over five years.

Scientists supporting mission to assess Europa’s habitability

NASA's Europa Clipper mission blasted off to the moon of Jupiter on Oct. 14. Cornell researchers will help determine if the ocean world could support life.

Magnetically regulated gene therapy tech offers precise brain-circuit control

A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.

Study finds mutations, DNA structures driving bladder cancer

A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.